DRW Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$422K Sell
459
-4,707
-91% -$4.77M 0.01% 698
2025
Q4
$5.55M Sell
5,166
-797
-13% -$762K 0.15% 112
2025
Q3
$4.55M Buy
5,963
+3,100
+108% +$2.31M 0.08% 134
2025
Q2
$2.23M Sell
2,863
-8,159
-74% -$6.34M 0.05% 198
2025
Q1
$9.1M Buy
11,022
+9,246
+521% +$7.69M 0.25% 55
2024
Q4
$1.37M Buy
1,776
+603
+51% +$499K 0.05% 190
2024
Q3
$1.04M Sell
1,173
-737
-39% -$663K 0.03% 275
2024
Q2
$1.74M Sell
1,910
-4,392
-70% -$3.51M 0.07% 171
2024
Q1
$4.9M Buy
6,302
+3,882
+160% +$2.76M 0.13% 68
2023
Q4
$1.41M Buy
2,420
+1,168
+93% +$682K 0.02% 121
2023
Q3
$672K Sell
1,252
-752
-38% -$388K 0.01% 185
2023
Q2
$940K Sell
2,004
-2,157
-52% -$905K 0.02% 161
2023
Q1
$1.43M Buy
+4,161
New +$1.4M 0.02% 114
2022
Q4
Sell
-3,143
Closed -$1.02M 307
2022
Q3
$1.02M Buy
3,143
+1,316
+72% +$417K 0.02% 118
2022
Q2
$592K Sell
1,827
-1,456
-44% -$437K 0.01% 137
2022
Q1
$940K Buy
3,283
+1,154
+54% +$297K 0.03% 132
2021
Q4
$588K Buy
+2,129
New +$540K 0.02% 128
2021
Q3
Sell
-2,782
Closed -$639K 327
2021
Q2
$639K Buy
+2,782
New +$559K 0.02% 162
2020
Q2
Sell
-16,983
Closed -$2.36M 268
2020
Q1
$2.36M Buy
+16,983
New +$2.33M 0.09% 58
2018
Q1
Sell
-13,584
Closed -$1.15M 348
2017
Q4
$1.15M Buy
+13,584
New +$1.16M 0.12% 108

Other funds holding LLY

DRW Securities's LLY Position: Q1 2026 in Review

DRW Securities reduced its Eli Lilly (LLY) stake by 91% in Q1 2026, selling an estimated $4.77M and leaving 459 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #698.

DRW Securities first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $9.1M in Q1 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • DRW Securities held 459 shares of Eli Lilly worth $422K as of Q1 2026.
  • DRW Securities sold 4,707 Eli Lilly shares in Q1 2026, an estimated $4.77M.
  • Eli Lilly made up 0.01% of DRW Securities's portfolio in Q1 2026, its #698 holding.
  • DRW Securities first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
  • DRW Securities's Eli Lilly position peaked at $9.1M in Q1 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.